XML 25 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash Flows from Operating Activities      
Net income $ 85.0 $ 61.8 $ 81.3
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization [1] 49.6 50.4 38.1
Adjustment to fair value of contingent consideration 0.0 0.0 (9.4)
Loss on disposal of subsidiary 0.0 0.9 1.4
Foreign exchange loss on liquidation of subsidiary 0.0 1.8 0.0
Deferred tax expense/(benefit) 5.5 (6.7) 0.9
Cash contributions to defined benefit pension plans (1.0) (1.0) (1.1)
Non-cash income of defined benefit pension plans (4.3) (3.6) (6.2)
Stock option compensation 4.9 4.1 3.3
Changes in assets and liabilities, net of effects of acquired and divested companies:      
Trade and other accounts receivable (40.1) (83.2) (6.0)
Inventories (42.2) (30.8) 7.7
Prepaid expenses 0.5 (6.8) 0.5
Accounts payable and accrued liabilities 38.4 48.6 (3.4)
Accrued income taxes (6.1) 47.5 (2.0)
Plant closure provisions 3.6 3.8 1.9
Unrecognized tax benefits 11.5 (0.5) (1.6)
Other assets and liabilities (0.4) (3.6) 0.1
Net cash provided by operating activities 104.9 82.7 105.5
Cash Flows from Investing Activities      
Capital expenditures (28.9) (23.3) (16.5)
Business combinations, net of cash acquired (5.4) 2.6 (197.4)
Acquisition of intangible asset 0.0 (4.2) 0.0
Internally developed software (1.2) (4.7) 0.0
Sale of short-term investments 0.0 0.0 4.8
Net cash used in investing activities (35.5) (29.6) (209.1)
Cash Flows from Financing Activities      
Proceeds from revolving credit facility 10.0 10.0 48.0
Repayments of revolving credit facility (5.0) (50.0) (20.0)
(Payment)/receipt of term loans (16.5) (11.0) 110.0
Repayment of finance leases and term loans (2.7) (2.5) (1.1)
Refinancing costs 0.0 0.0 (1.2)
Payment for acquisition-related contingent consideration 0.0 0.0 (44.0)
Dividend paid (21.7) (18.6) (15.9)
Issue of treasury stock 1.1 6.8 2.1
Repurchase of common stock (1.4) (1.1) (8.4)
Net cash (used in)/provided by financing activities (36.2) (66.4) 69.5
Effect of foreign currency exchange rate changes on cash (0.3) 1.6 (0.9)
Net change in cash and cash equivalents 32.9 (11.7) (35.0)
Cash and cash equivalents at beginning of year 90.2 101.9 136.9
Cash and cash equivalents at end of year $ 123.1 $ 90.2 $ 101.9
[1] Amortization of deferred finance costs of $0.7 million (2017 - $0.6 million, 2016 - $0.4 million) for the year are included in depreciation and amortization in the cash flow statement but in interest expense in the income statement. Cash payments/receipts in respect of income taxes and interest are disclosed in Note 10 and Note 11, respectively, of the Notes to the Consolidated Financial Statements.